3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Neoplastic Cells, Circulating
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
Blood Specimen Collection
25
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Liquid Biopsy
4
cabazitaxel
3
Surgical Procedures, Operative
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Trastuzumab
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
ribociclib
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplastic Cells, Circulating
×
Histamine H2 Antagonists
×
Clear all
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled